On December 18, 2025, BioRender announced that it facilitated a secondary purchase by Dimension Capital at a $900-million valuation.
BioRender is a web-based platform that crafts and shares visually engaging scientific figures for communication and publication purposes.
Osler, Hoskin & Harcourt LLP advised BioRender with a team consisting of Chad Bayne, Gary Marshall and Sahil Chopra (Emerging and High Growth Companies).
Key Contact
Partner, Emerging and High Growth Companies, Toronto
Team
Partner, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto